Check out our Q&A section on REACH Authorisation
12 new substances have been added to the REACH Annex XIV with a latest application date of 1 January 2019. There are new challenges for the industry as for the first time substances with endocrine disrupting properties have been included in the authorisation list.
To help companies understand the requirements to be met to successfully complete their authorisation applications we have created a comprehensive Q&A section in our website where you can get answers to the most frequently asked questions.
Interested? Visit our Q&A via the following link: https://www.reachlaw.fi/services/market-access-services/reach-authorisation-services/
Didn’t find the answer you were looking for? Write us an email to email@example.com we would be very glad to assist you